Management of antihypertensive drugs in three European countries

作者
Federica Nicotra,Björn Wettermark,Miriam Sturkenboom,Andrea Ferretto Parodi,Rino Bellocco,Anders Ekbom,Luca Giuseppe Merlino,Andrejs Leimanis,Giuseppe Mancia,Michael Fored,Giovanni Corrao
出处
期刊:Journal of Hypertension [Lippincott Williams & Wilkins]
卷期号:27 (9): 1917-1922 被引量:24
标识
DOI:10.1097/hjh.0b013e32832d4692
摘要

OBJECTIVES: To compare rates of treatment discontinuation of and changes in initial antihypertensive drug therapy in the natural setting of treatment dispensation of Italy, Sweden and the Netherlands. METHODS: The cohorts included all the 23 715 (Italy), 20 289 (Sweden), and 5801 (the Netherlands) patients aged 40-70 years who received their first antihypertensive drug prescription from July 1, 2006 to September 30, 2006. Discontinuation was assumed if no antihypertensive drug was issued within 90 days following the end of the latest antihypertensive dispensation. Addition or replacement of the initial medication during the 90-day interval were defined as treatment combination or treatment switching. RESULTS: At 9 months after treatment initiation, the discontinuation rate of any antihypertensive drug was 24%. Compared with Italian patients, the discontinuation rate was significantly lower in Swedish [hazard ratios: 0.52, 95% confidence interval (CI): 0.50-0.54] and Dutch patients (hazard ratio: 0.79, 95% CI: 0.75-0.84). Almost 21 and 16% of patients who started on monotherapy respectively combined with and switched to another antihypertensive drug. Compared with Italian patients, the adjusted hazard rate of combining was lower in Swedish patients (hazard ratio: 0.83, 95% CI: 0.79-0.87). The hazard rate of switching was lower in Swedish and Dutch patients than in Italians (hazard ratios: 0.83, 95% CI: 0.79-0.88 and hazard ratio: 0.77, 95% CI: 0.71-0.84 respectively). CONCLUSION: Management of hypertension is unsatisfactory worldwide due to a very high rate of treatment discontinuation or insufficient use of proper treatment strategies.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
卜算子发布了新的文献求助10
刚刚
Yuan88发布了新的文献求助10
刚刚
小光发布了新的文献求助10
刚刚
西瓜一块两块完成签到,获得积分10
1秒前
汉堡包的应助被elara采纳,获得10
1秒前
Tmac完成签到,获得积分10
1秒前
云舒完成签到 ,获得积分10
1秒前
大力怀绿完成签到,获得积分10
1秒前
yyy完成签到,获得积分10
1秒前
希屿完成签到,获得积分10
1秒前
Ning完成签到,获得积分10
2秒前
yangyangyang完成签到,获得积分0
2秒前
sens完成签到,获得积分10
2秒前
2秒前
昏睡的洋葱完成签到,获得积分10
2秒前
无花果的应助被呢喃采纳,获得10
3秒前
鸟窝的应助被li采纳,获得10
3秒前
科目三的应助被搞怪花生采纳,获得10
3秒前
小白完成签到 ,获得积分10
3秒前
牛马发布了新的文献求助10
3秒前
米多奇完成签到,获得积分10
3秒前
鱼跃完成签到,获得积分10
4秒前
呵呵喊我完成签到,获得积分10
4秒前
ZhangCS完成签到,获得积分10
4秒前
张张完成签到,获得积分10
4秒前
劳模老徐完成签到 ,获得积分10
4秒前
gyq完成签到,获得积分10
4秒前
Axel发布了新的文献求助10
4秒前
4秒前
派兀派完成签到,获得积分10
5秒前
oyy318完成签到,获得积分10
5秒前
稳重的水池完成签到,获得积分10
5秒前
歪比巴卜完成签到 ,获得积分10
5秒前
5秒前
单纯草丛完成签到,获得积分10
5秒前
seven完成签到,获得积分10
5秒前
DPBHX完成签到,获得积分10
6秒前
搜集达人的应助被kong采纳,获得10
6秒前
甜甜镜子完成签到,获得积分10
6秒前
ryoung3完成签到 ,获得积分10
6秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8173729
求助须知:如何正确求助?哪些是违规求助? 9565870
关于积分的说明 21782999
捐赠科研通 7767898
什么是DOI,文献DOI怎么找? 3431625
关于科研通互助平台的介绍 2555879
邀请新用户注册赠送积分活动 2476903